Lurbinectedin, a novel anticancer drug, has shown promise in clinical trials for the treatment of breast cancer. It works by inhibiting BET proteins, disrupting gene expression, and causing cancer cell death. Despite potential challenges, such as possible toxicity and neutropenia, the results of clinical trials show that Lurbinectedin could be an effective treatment option for breast cancer patients.
SSH Auth Key Reuse Uncovers Advanced Targeted Phishing Campaign
Researchers from Hunt.io have identified a phishing campaign targeting several sectors in Kuwait, including fisheries, telecommunications and insurance. The ongoing operation which began in early
